MedWatch

Lundbeck wins European approval for alcohol pill

The EU Commission has awarded marketing authorization to a pill from the Danish company Lundbeck for the treatment of alcohol addiction. The company estimates a top sales potential of several billions, while analysts are more cautious.

Foto: Colourbox

Lundbeck’s new drug for alcohol addiction is ready to help European patients after the EU Commission Thursday told the company that its application for marketing of the drug had been approved.

“Selincro represents the first major innovation in the treatment of alcohol dependence in many years," says Executive Vice President Anders Gersel Pedersen, Head of Research & Development at Lundbeck in a press release, and continues:

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier